This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shephard AJ, Mahmood H, Raza SEA, Khurram SA, Rajpoot NM. A novel AI-based score for assessing the prognostic value of intra-epithelial lymphocytes in oral epithelial dysplasia. Br J Cancer. 2025;132:168–79.
Conway C, Graham JL, Chengot P, Daly C, Chalkley R, Ross L, et al. Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq. Oncotarget. 2015;6:40186–201.
Gilvetti C, Soneji C, Bisase B, Barrett AW. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit. Oral Oncol. 2021;121:105462.
Lassau N, Bousaid I, Chouzenoux E, Lamarque JP, Charmettant B, Azoulay M, et al. Three artificial intelligence data challenges based on CT and MRI. Diagn Inter Imaging. 2020;101:783–8.
Rakha EA, Toss M, Shiino S, Gamble P, Jaroensri R, Mermel CH, et al. Current and future applications of artificial intelligence in pathology: a clinical perspective. J Clin Pathol. 2021;74:409–14.
Author information
Authors and Affiliations
Contributions
PKY and CMA Conception, data analysis, interpretation, and manuscript drafting.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ardila, C.M., Yadalam, P.K. Expanding the horizon of prognostic markers in oral epithelial dysplasia: a critical appraisal of the novel AI-based IEL score. Br J Cancer 132, 755–756 (2025). https://doi.org/10.1038/s41416-025-03010-8
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41416-025-03010-8